Advancements in Chronic Kidney Disease Management: Exploring the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Guidelines: Homestudy

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

Define chronic kidney disease (CKD) and the clinical consequences of CKD progression.
Identify methods for evaluating and classifying the severity of CKD.
State the Kidney Disease Improving Global Outcomes (KDIGO) recommendations for the pharmacologic prevention of CKD progression.
Recall literature supporting pharmacotherapeutic options to slow or prevent the progression of CKD.

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
04/24/2024
Course expires: 
04/09/2026
Cost:
$10.00
Rating: 
0

Christopher Donaldson, PharmD
PGY1 Pharmacy Resident, The Brooklyn Hospital Center
 

Christopher is a graduate of the Medical University of South Carolina and a current resident at The Brooklyn Hospital Center. Upon completion of his PGY1 residency program, Christopher will continue his training in Infectious Disease as a PGY2 resident at The Brooklyn Hospital Center
 

ACPE UAN 0042-0000-24-029-H01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$10.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.